RLAY
Relay Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -4.9% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +5 | 111.06M | $2.04B | +12 | −7 |
| Q1 2026 | 92 | +9 | 68.30M | $679.13M | +15 | −7 |
| Q4 2025 | 84 | +2 | 73.82M | $624.52M | +3 | — |
| Q3 2025 | 14 | -1 | 56.07M | $292.70M | — | −2 |
| Q2 2025 | 13 | 0 | 54.62M | $188.99M | +1 | −1 |
| Q1 2025 | 10 | -2 | 33.93M | $88.91M | — | −2 |
| Q4 2024 | 12 | 0 | 26.38M | $108.69M | — | — |
| Q3 2024 | 11 | 0 | 24.01M | $170.03M | +2 | −2 |
| Q2 2024 | 11 | — | 15.37M | $100.25M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 13.95M | — | $48.28M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 13.45M | +24.2% | $46.52M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passive) | 9.38M | — | $32.45M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passive) | 9.38M | — | $32.45M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passive) | 9.38M | — | $32.45M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passive) | 9.38M | — | $32.45M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passive) | 9.38M | — | $32.45M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passive) | 5.20M | +0.8% | $18.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passive) | 3.23M | +5.2% | $11.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passive) | 3.23M | +5.2% | $11.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 2.88M | -17.3% | $9.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 2.88M | -17.3% | $9.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Millennium Management ✦ | 1.87M | -36.4% | $6.47M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 1.51M | -33.7% | $5.22M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 1.08M | +196.9% | $3.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 1.08M | +196.9% | $3.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 1.08M | +196.9% | $3.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 1.08M | +196.9% | $3.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 1.08M | +196.9% | $3.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 1.02M | +21.3% | $3.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Norges Bank ✦ (passive) | 835.87K | -82.0% | $2.89M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Fidelity (FMR) ✦ | 158.18K | — | $547,301 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 158.18K | — | $547,301 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Marshall Wace ✦ | 51.70K | New | $178,874 | 0.0% | New | 1 | SEC ↗ |
| 36 | Marshall Wace ✦ | 51.70K | New | $178,874 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $178,874 | 0.0% |
| Marshall Wace | $178,874 | 0.0% |
Exited
| Citadel Advisors | $883,642 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 240 holders, 183.00M shares, $1.79B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 17.72K sh · $349,734
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology